Invited Speaker: Robert A. Kesterson, PhD – UAB “CRISPRs & Gene Editing: Laboratory Use & Clinical Future”
Christine Eng, MD — Clinical Whole Exome Sequencing For the Evaluation of Genetic Disorders (SERN/SERGG 2013)
Dr. Eng presents on whole exome sequencing.
Clinical Application of Microarray Technology on Hematological Malignancies and Solid Tumor: The CCMC Experience
Dr. Li presents at the 2010 SERGG Annual Meeting.
Dr. Barry Smith presents on biomedical ontology. This is the second in a two-part series.
Stuart Shapira, MD, PhD — Routine Second Testing in Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia: Is One Screening Test Sufficient? (SERN/SERGG 2012)
Dr. Shapira presents on Newborn Screening for Hypothyroidism and Congenital Adrenal Hyperplasia.
Invited Speaker: Emily Lisi, MS, CGC – Mayo Clinic “The Current Status of Direct-to-Consumer Genetic Testing”
Dr. Verma presents on genetics in India.
Muin Khoury, MD, PhD — The Scientific Foundation for Using Personal Genomics to Improve Health and Prevent Disease (SERN/SERGG 2011)
Dr. Khoury presents at the 2011 SERC-SERGG Annual Conference.
Dr. Ledbetter presents at the 2010 SERGG Annual Meeting.
Dr. Barry Smith presents on biomedical ontology. This is the first of a two-part lecture.
Dr. Brilliant presents at the 2010 SERGG Annual Meeting.
Hutton Kearney, PhD, FACMG — Navigating uncertainty and unexpected findings in whole genome array testing: A discussion of interpretation and reporting strategies (SERN/SERGG 2013)
Dr. Kearney presents on genome array testing.
Ms. Kristy Lee presents, Challenges in Interpretation & Explanation of Exome Sequencing.
Dr. Bick presents, “Whole Genome Sequencing – It’s Time Has Arrived”
Dr. Watson presents, “LTDs and the FDA”
Deeksha Bali, PhD, FACMG — Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory (SERN/SERGG 2015)
Dr. Bali presents Diagnostic confirmation of Pompe Disease: experience of a clinical laboratory.